Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $4,279 | 242 | 81.7% |
| Travel and Lodging | $494.53 | 4 | 9.4% |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $450.00 | 3 | 8.6% |
| Education | $16.14 | 1 | 0.3% |
| Unspecified | $0 | 2 | 0.0% |
Payments by Type
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| ABBVIE INC. | $1,013 | 62 | $0 (2024) |
| Covidien LP | $794.64 | 7 | $0 (2019) |
| Shire North American Group Inc | $640.89 | 14 | $0 (2018) |
| Takeda Pharmaceuticals U.S.A., Inc. | $583.45 | 28 | $0 (2020) |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | $340.06 | 25 | $0 (2024) |
| Takeda Pharmaceuticals America, Inc. | $218.73 | 12 | $0 (2017) |
| Gilead Sciences, Inc. | $166.88 | 12 | $0 (2022) |
| Allergan Inc. | $145.66 | 10 | $0 (2019) |
| Valeant Pharmaceuticals North America LLC | $142.54 | 11 | $0 (2017) |
| Janssen Biotech, Inc. | $141.89 | 10 | $0 (2019) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $356.34 | 21 | ABBVIE INC. ($138.67) |
| 2023 | $212.51 | 17 | AbbVie Inc. ($127.24) |
| 2022 | $131.42 | 6 | ABBVIE INC. ($49.07) |
| 2021 | $19.40 | 1 | Celgene Corporation ($19.40) |
| 2020 | $146.92 | 8 | Takeda Pharmaceuticals U.S.A., Inc. ($58.76) |
| 2019 | $931.95 | 47 | Covidien LP ($241.47) |
| 2018 | $1,643 | 71 | Shire North American Group Inc ($510.54) |
| 2017 | $1,798 | 81 | Covidien LP ($553.17) |
All Payment Transactions
252 individual payment records from CMS Open Payments — Page 1 of 11
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/13/2024 | Madrigal Pharmaceuticals | RESMETIROM (Drug) | Food and Beverage | In-kind items and services | $29.82 | General |
| Category: LIVER DISEASE | ||||||
| 11/13/2024 | Ardelyx, Inc. | IBSRELA (Drug) | Food and Beverage | In-kind items and services | $21.68 | General |
| Category: GASTROENTEROLOGY | ||||||
| 10/23/2024 | Phathom Pharmaceuticals, Inc. | VOQUEZNA (Drug) | Food and Beverage | In-kind items and services | $19.07 | General |
| Category: GASTROENTEROLOGY | ||||||
| 10/23/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | TRULANCE (Drug) | Food and Beverage | In-kind items and services | $18.59 | General |
| Category: Gastroenterology | ||||||
| 10/21/2024 | ABBVIE INC. | SKYRIZI (Biological), RINVOQ | Food and Beverage | In-kind items and services | $21.60 | General |
| Category: IMMUNOLOGY | ||||||
| 09/27/2024 | ABBVIE INC. | VIBERZI (Drug), CREON | Food and Beverage | In-kind items and services | $17.32 | General |
| Category: GASTROENTEROLOGY | ||||||
| 09/25/2024 | Ardelyx, Inc. | IBSRELA (Drug) | Food and Beverage | In-kind items and services | $21.77 | General |
| Category: GASTROENTEROLOGY | ||||||
| 08/16/2024 | Phathom Pharmaceuticals, Inc. | VOQUEZNA (Drug) | Food and Beverage | In-kind items and services | $24.76 | General |
| Category: GASTROENTEROLOGY | ||||||
| 08/12/2024 | GENZYME CORPORATION | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $19.49 | General |
| Category: Immunology | ||||||
| 07/29/2024 | ABBVIE INC. | CREON (Drug), LINZESS | Food and Beverage | In-kind items and services | $14.22 | General |
| Category: ENDOCRINOLOGY | ||||||
| 07/29/2024 | ABBVIE INC. | SKYRIZI (Biological), RINVOQ | Food and Beverage | In-kind items and services | $11.62 | General |
| Category: IMMUNOLOGY | ||||||
| 07/18/2024 | PFIZER INC. | XELJANZ (Drug), VELSIPITY | Food and Beverage | In-kind items and services | $19.33 | General |
| Category: GASTROINTESTINAL;INFLAMMATION;OPHTHALMOLOGY;TRANSPLANT | ||||||
| 07/12/2024 | ABBVIE INC. | RINVOQ (Biological), SKYRIZI | Food and Beverage | In-kind items and services | $20.55 | General |
| Category: IMMUNOLOGY | ||||||
| 06/06/2024 | Ardelyx, Inc. | IBSRELA (Drug) | Food and Beverage | In-kind items and services | $21.49 | General |
| Category: GASTROENTEROLOGY | ||||||
| 05/02/2024 | ABBVIE INC. | CREON (Drug), LINZESS | Food and Beverage | In-kind items and services | $13.92 | General |
| Category: ENDOCRINOLOGY | ||||||
| 03/12/2024 | ABBVIE INC. | CREON (Drug), LINZESS | Food and Beverage | In-kind items and services | $6.77 | General |
| Category: ENDOCRINOLOGY | ||||||
| 03/11/2024 | Phathom Pharmaceuticals, Inc. | VOQUEZNA (Drug) | Food and Beverage | In-kind items and services | $21.67 | General |
| Category: GASTROENTEROLOGY | ||||||
| 02/09/2024 | ABBVIE INC. | LINZESS (Drug), CREON | Food and Beverage | In-kind items and services | $14.88 | General |
| Category: GASTROENTEROLOGY | ||||||
| 01/30/2024 | ABBVIE INC. | CREON (Drug), LINZESS | Food and Beverage | In-kind items and services | $7.18 | General |
| Category: ENDOCRINOLOGY | ||||||
| 01/02/2024 | ABBVIE INC. | CREON (Drug), VIBERZI, LINZESS | Food and Beverage | In-kind items and services | $10.61 | General |
| Category: ENDOCRINOLOGY | ||||||
| 2024 | GastroGPO, LLC | — | — | — | $0.00 | Ownership |
| 12/12/2023 | AbbVie Inc. | CREON (Drug), VIBERZI, LINZESS | Food and Beverage | In-kind items and services | $16.01 | General |
| Category: ENDOCRINOLOGY | ||||||
| 12/01/2023 | AbbVie Inc. | CREON (Drug), VIBERZI, LINZESS | Food and Beverage | In-kind items and services | $10.15 | General |
| Category: ENDOCRINOLOGY | ||||||
| 11/06/2023 | AbbVie Inc. | LINZESS (Drug) | Food and Beverage | In-kind items and services | $14.86 | General |
| Category: GASTROENTEROLOGY | ||||||
| 11/01/2023 | AbbVie Inc. | VIBERZI (Drug), LINZESS | Food and Beverage | In-kind items and services | $7.42 | General |
| Category: GASTROENTEROLOGY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 8 | 345 | 385 | $250,655 | $40,338 |
| 2022 | 12 | 409 | 469 | $266,133 | $43,443 |
| 2021 | 9 | 349 | 425 | $192,600 | $40,448 |
| 2020 | 12 | 371 | 473 | $187,903 | $40,822 |
All Medicare Procedures & Services
41 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 80 | 116 | $29,348 | $11,648 | 39.7% |
| 45385 | Removal of polyps or growths of large bowel using an endoscope with mechanical snare | Facility | 2023 | 34 | 34 | $49,256 | $7,238 | 14.7% |
| 45380 | Biopsy of large bowel using a flexible endoscope | Facility | 2023 | 60 | 61 | $71,797 | $6,438 | 9.0% |
| 43239 | Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | Facility | 2023 | 81 | 84 | $68,838 | $6,193 | 9.0% |
| 99222 | Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | Facility | 2023 | 24 | 24 | $7,392 | $2,529 | 34.2% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 30 | 30 | $5,610 | $2,221 | 39.6% |
| G0105 | Colorectal cancer screening; colonoscopy on individual at high risk | Facility | 2023 | 12 | 12 | $12,474 | $2,214 | 17.7% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 24 | 24 | $5,940 | $1,857 | 31.3% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 97 | 135 | $33,764 | $13,335 | 39.5% |
| 45380 | Biopsy of large bowel using a flexible endoscope | Facility | 2022 | 69 | 71 | $82,711 | $8,010 | 9.7% |
| 45385 | Removal of polyps or growths of large bowel using an endoscope with mechanical snare | Facility | 2022 | 30 | 31 | $43,988 | $6,136 | 13.9% |
| 43239 | Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | Facility | 2022 | 69 | 70 | $56,546 | $5,479 | 9.7% |
| 99222 | Initial hospital inpatient care per day, typically 50 minutes | Facility | 2022 | 30 | 31 | $9,492 | $3,396 | 35.8% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2022 | 25 | 25 | $6,120 | $2,095 | 34.2% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 20 | 21 | $3,859 | $1,416 | 36.7% |
| 45378 | Diagnostic exam of large bowel using a flexible endoscope | Facility | 2022 | 11 | 11 | $10,962 | $1,339 | 12.2% |
| 99232 | Follow-up hospital inpatient care per day, typically 25 minutes | Facility | 2022 | 16 | 17 | $2,548 | $1,019 | 40.0% |
| 91010 | Study of esophagus to assess movement | Facility | 2022 | 15 | 15 | $8,200 | $778.06 | 9.5% |
| 91034 | Monitoring and recording of esophageal function through nasal tube | Facility | 2022 | 11 | 11 | $6,600 | $424.24 | 6.4% |
| J7050 | Infusion, normal saline solution, 250 cc | Office | 2022 | 16 | 31 | $1,344 | $16.12 | 1.2% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 92 | 129 | $25,800 | $13,387 | 51.9% |
| 45380 | Biopsy of the large bowel using an endoscope (colonoscopy) | Facility | 2021 | 58 | 58 | $62,060 | $7,866 | 12.7% |
| 45385 | Removal of polyps or growths in large bowel using an endoscope (colonoscopy) using a mechanical snare | Facility | 2021 | 25 | 25 | $32,925 | $5,145 | 15.6% |
| 43239 | Biopsy of the esophagus, stomach, and/or upper small bowel using an endoscope | Facility | 2021 | 61 | 64 | $47,680 | $5,102 | 10.7% |
| 99222 | Initial hospital inpatient care, typically 50 minutes per day | Facility | 2021 | 35 | 36 | $10,080 | $4,154 | 41.2% |
About Dr. Jonathan White, M.D
Dr. Jonathan White, M.D is a Gastroenterology healthcare provider based in Meriden, Connecticut. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 03/02/2007. The National Provider Identifier (NPI) number assigned to this provider is 1598893224.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Jonathan White, M.D has received a total of $5,240 in payments from pharmaceutical and medical device companies, with $356.34 received in 2024. These payments were reported across 252 transactions from 31 companies. The most common payment nature is "Food and Beverage" ($4,279).
As a Medicare-enrolled provider, White has provided services to 1,474 Medicare beneficiaries, totaling 1,752 services with total Medicare billing of $165,050. Data is available for 4 years (2020–2023), covering 41 distinct procedure/service records.
Practice Information
- Specialty Gastroenterology
- Location Meriden, CT
- Active Since 03/02/2007
- Last Updated 08/24/2011
- Taxonomy Code 207RG0100X
- Entity Type Individual
- NPI Number 1598893224
Products in Payments
- Barrx (Device) $553.17
- Amitiza (Drug) $458.72
- Humira (Biological) $425.49
- GATTEX (Drug) $393.00
- Entyvio (Biological) $243.31
- XIFAXAN (Drug) $232.69
- LINZESS (Drug) $223.83
- EndoFlip (Device) $217.23
- Creon (Drug) $192.67
- STELARA (Biological) $128.67
- UCERIS (Drug) $113.94
- Cimzia (Drug) $106.76
- VIBERZI (Drug) $106.19
- INJECTAFER (Drug) $101.97
- TRULANCE (Drug) $100.98
- ZENPEP (Drug) $89.75
- SKYRIZI (Biological) $82.29
- CREON (Drug) $78.86
- VOQUEZNA (Drug) $65.50
- IBSRELA (Drug) $64.94
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Gastroenterology Doctors in Meriden
Dr. Housein Wazaz, M.d, M.D
Gastroenterology — Payments: $224,639
Kevin Jo, M.d, M.D
Gastroenterology — Payments: $7,216
Jon Ernstoff, M.d, M.D
Gastroenterology — Payments: $4,491
Lawrence Kogan, Md, MD
Gastroenterology — Payments: $371.99
Janet Dickinson, Md, MD
Gastroenterology